WX-02-43, CAS [[2929223-36-7]]

Artikelnummer: MCE-HY-181421
Artikelname: WX-02-43, CAS [[2929223-36-7]]
Artikelnummer: MCE-HY-181421
Hersteller Artikelnummer: HY-181421
Alternativnummer: MCE-HY-181421-50MG,MCE-HY-181421-100MG,MCE-HY-181421-10MMX1ML,MCE-HY-181421-5MG,MCE-HY-181421-10MG,MCE-HY-181421-25MG
Hersteller: MedchemExpress
Kategorie: Biochemikalien
WX-02-43 is a weak covalent inhibitor of SF3B1, and is the (1S,3R) enantiomer of WX-02-23 (HY-168534). WX-02-43 cannot effectively covalently modify the C258 site in the DNA-binding domain of FOXA1, and its inhibitory activity against SF3B1 is also weaker than that of WX-02-23. WX-02-43 serves as a negative control probe that fails to remodel the chromatin binding pattern and transcriptional activity of FOXA1. WX-02-43 can be used in studies on cancers such as prostate cancer to verify the specific effects of WX-02-23 on FOXA1 and SF3B1 targets[1][2][3].
Molekulargewicht: 459.49
Reinheit: 99.49
CAS Nummer: [2929223-36-7]
Formel: C26H25N3O5
Target-Kategorie: SF3B1
Anwendungsbeschreibung: MCE Product type: Reference compound